Clinical studies recruiting near Encino

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · UCLA Hematology/Oncology - Encino · Pfizer · NCT07028853 Prospective Study on Power Prenatal Vitamins for Males on YO Score At-home Sperm Test Results
NA · Medical Electronic Systems · The Bird and Be Co Inc · NCT05951075 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Leading Edge Research LA, LLC · Kallyope Inc. · NCT07674654 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · The Retina Partners · Astellas Pharma Global Development, Inc. · NCT06779773 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · Alkermes Investigator Site · Alkermes, Inc. · NCT05303064 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site_2 · Intra-Cellular Therapies, Inc. · NCT06701903 Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne
Phase 1/Phase 2 · Encino Research Center- Site Number : 8400008 · Sanofi Pasteur, a Sanofi Company · NCT07013747 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 172 · Adverum Biotechnologies, Inc. · NCT07482176 Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT07590934 FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-S
Phase 2 · Clinical Research Advisors (Encino) · Oncolytics Biotech · NCT07446322 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1151 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Phase 2/Phase 3 · Encino Research Center · Bluefin Biomedicine, Inc. · NCT07287644 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · Encino Research Center- Site Number : 8401042 · Sanofi · NCT06241118 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1033 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Clinical Research Advisors - Encino · OSE Immunotherapeutics · NCT06472245 Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06413433 Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Phase 3 · Site 69 · Veradermics, Inc. · NCT07146022 Extension Study for the Port Delivery System With Ranibizumab (Portal)
Phase 3 · The Retina Partners · Hoffmann-La Roche · NCT03683251 MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Clinical Research Advisors (Encino Satellite Location) · Pfizer · NCT06152575 A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · Private Practice - Dr. Tooraj Raoof /ID# 254374 · AbbVie · NCT05889182 Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without C
Phase 2/Phase 3 · The Retina Partners /ID# 274741 · AbbVie · NCT07592273 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1151 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT06126224 A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · Private Practice - Dr. Tooraj Raoof /ID# 263849 · AbbVie · NCT06389136 Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Phase 3 · Leading Edge Research LA, LLC · Suven Life Sciences Limited · NCT05397639 Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Phase 2 · Wr-Pri, Llc · Syndeio Biosciences, Inc · NCT06547489 Fertilo In Vitro Research Study and Trial
Phase 3 · HRC Fertility · Gameto, Inc. · NCT06858111 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Encino Outpatient Surg Ctr · Stryker Instruments · NCT03072927 Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Phase 3 · T. Joseph Raoof MD Inc · Bristol-Myers Squibb · NCT07116967 COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · The Retina Partners · EyePoint Pharmaceuticals, Inc. · NCT07449936

Look up another city

Look up another condition